Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol
In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire
Interactive R01 Scores Vary widely, Result Of separate Review
Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes
ASCO Honors Holland, Koop, Monaco With Special Awards
ONS To Fund 21 Grants In ’94 Deadline Dec. 1
Prevention & Control Study Section Needed: Letter to the Editor
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - Scaling excellence: How City of Hope is transforming cancer care delivery
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest